2016 Global Forum on Responsible Business Conduct - DAY 2
Thursday 9 June 2016
Download full agenda |
Day 1 programme |
Tweet #OECDrbc |
08:00 - 09:30 |
Registration |
||
09:30 - 11:00 Room CC10 |
Measuring links between business performance and responsible business conduct This session will discuss latest empirical evidence on the impact of RBC on business performance, such as improved financial returns, increased access to credit, employee retention, and the costs of implementing due diligence and other RBC actions. It will address questions of what metrics and indicators are used to measure this impact, as well as challenges and strategies related to collecting the relevant information and establishing causality. Session note Moderator
|
||
11:00 - 11:30 |
Coffee break |
||
11:30 - 13:00 Room CC10
|
Taking stock of National Contact Point activities National Contact Points have a mandate to promote the Guidelines and handle complaints regarding non-observance of the Guidelines in specific instances. The nature of specific instances brought to NCPs has varied over the years. This session will look back at these specific instances and discuss outcomes and follow-up measures. In addition, the session will hear from National Human Rights Institutions, some of which are beginning to receive complaints related to business activities. Session note 15 years of the National Contact Points Moderator
Panellists
|
11:30 - 13:00 Auditorium |
Multi-stakeholder initiatives and RBC A large number of multi-stakeholder initiatives (MSIs) have emerged in the past two decades to help business identify and avoid adverse environmental, labour and human rights impacts in global supply chains. The session will include experts as well as participants from national and international MSIs to reflect on their experiences to date, and draw broad lessons that could help strengthen collaborative engagement on responsible business conduct in the future. This session will also explore how countries can strengthen MSIs and how MSIs can measure their effectiveness and impact. Session note
Panellists
|
13:00 - 14:30 CC10 |
Lunch break OECD lunchtime session: Introduction to General Due Diligence Guidance The OECD Guidelines for Multinational Enterprises seek to shift corporate thinking about risks. For many companies, the term risk means risks to the company itself, such as financial risk, operational risk and reputational risk. The OECD Guidelines call on companies to carry out risk-based due diligence to avoid and address adverse impacts related to matters covered by the Guidelines, focusing instead on risks associated with enterprise activities and the consequences for society, for human rights, the environment and governance. This lunchtime session will introduce OECD’s new project to develop a general Guidance on Due Diligence for Responsible Business Conduct relevant to all sectors of the economy. Session note
|
||
14:30 - 16:00 Auditorium |
Aligning fiduciary duty and responsible business conduct in institutional investments Over the past decade, changes in investment practice and in public policy have created positive duties on investors to integrate environmental, social and governance (ESG) issues into decision making where they are indeed financially material. Some have argued that failing to consider all long-term investment value drivers, including ESG issues, is a failure of fiduciary duty. Others, however, continue to perceive a misalignment between the expectation of institutional investors to prevent and mitigate ESG risks and the duty to generate a return on clients’ assets. This session explores how institutional investors can respond to the interests and expectations of their beneficiaries while also considering ESG issues. Session note Moderator
Panellists
|
||
16:00 - 16:30 |
Coffee Break |
||
16:30 - 18:00 Room CC10 |
Pharmaceutical industry and responsible business conduct According to WHO, three of the world’s most fatal communicable diseases - malaria, HIV/AIDS and tuberculosis - disproportionately affect the world’s poorest populations, placing a tremendous burden on the economies of developing countries. In light of the newly agreed Sustainable Development Goals, and in particular, Goal 3 to ensure healthy lives and promote well-being for all, this session will discuss what responsible business conduct means for pharmaceutical companies, in particular as related to their responsibility to facilitate access to medicine for vulnerable individuals. Session note Moderator
Panellists
|
16:30 - 18:00 Auditorium |
Accountability of Mega-Sporting Events This session will discuss new efforts to address human right and labour issues throughout the life-cycle of sporting events. Questions such as are we at a point where stakeholders can work together on building accountability measures that relate to the events themselves; what is the role for independent oversight, peer review, NCPs, arbitration as well as stronger national legal mechanisms; how do human rights and labour mechanisms sit along-side the wider measures needed to fight corruption and restore trust in sport, will be discussed. Sport, corruption and responsible business conduct Moderator
Panellists
|
18:00 - 18:30
Auditorium |
Closing plenary
This closing plenary will sum up the Global Forum discussions, with a focus on key considerations for ensuring that the Guidelines continue making an impact. Moderator
Panellists
|
> Go to the programme for day 1
> Download full agenda
The OECD is committed to measuring and reducing its environmental impacts.
This event is a sustainable event, organised in line with the OECD's environmental policy.
Related Documents